E. coli News and Research

RSS

E. coli or Escherichia coli is the name of a type of bacteria that lives in your intestines. Most types of E. coli are harmless. However, some types can make you sick and cause diarrhea. One type causes travelers' diarrhea. The worst type of E. coli causes bloody diarrhea, and can sometimes cause kidney failure and even death. These problems are most likely to occur in children and in adults with weak immune systems. You can get E. coli infections by eating foods containing the bacteria. To help avoid food poisoning and prevent infection, handle food safely. Cook meat well, wash fruits and vegetables before eating or cooking them, and avoid unpasteurized milk and juices. You can also get the infection by swallowing water in a swimming pool contaminated with human waste. Most cases of E. coli infection get better without treatment in 5 to 10 days.

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Scientists at the University of Kent and University College Cork have manipulated simple bacteria into constructing internal compartments where biofuels and vaccines can be produced.

14 Jun 2010

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

A team of researchers at Childrens Hospital Los Angeles (CHLA), along with colleagues from the Keck School of Medicine of the University of Southern California and the Universite Auvergne, France, have discovered an important role for a small, naturally occurring protein called interleukin-10 (IL-10) in removing bacteria from the blood of infected mice and reversing damage to the brain.

11 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

BioSpec Global Solutions Inc., and partner -ICBS Ltd., announced today that it has begun development of three new bio filter for the testing of E. coli, salmonella, listeria and pseudomonas in food samples. Development of the Antibody/antigen multiple discrete filters and optical system for the simultaneous analysis of E.coli, salmonella, listeria and pseudomonas in food samples.

7 Jun 2010

Discovery may pave way to help reduce health hazards

A discovery that may pave the way to helping reduce health hazards such as E. coli in water could also make chemicals and drugs such as insulin cheaper to produce and their production more environmentally friendly.

28 May 2010

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

The disease-causing bacterium E. coli O157:H7 is present but rare in some wildlife species of California's agriculturally rich Central Coast region, an area often referred to as the nation's "salad bowl," reports a team or researchers led by a UC Davis scientist.

28 May 2010

HZI researchers develop new method to produce insulin for treatment of diabetes

More than eight million diabetics live in Germany. Diabetes is not restricted to our prosperous society and the highest growth rates often occur in countries with aspiring economies such as in Asia. Worldwide, more than 285 million people suffer from this illness; with 50 million diabetics, India is the country with the most people affected by this disease.

27 May 2010

Family of EPA-registered disinfecting products to be launched

An innovative family of EPA-registered disinfecting products will be launched through a new direct selling company, it was announced today.

25 May 2010

Natural anti-inflammatory protein effective against meningitis-causing bacteria

A study published online on May 24th in the Journal of Experimental Medicine (www.jem.org) suggests that boosting the abundance of one of the body's own proteins might be more effective than antibiotic treatment at fighting off a common meningitis-causing bacterium (E. coli K1).

25 May 2010

Silver nanoparticles effective at killing all kinds of bacteria

Writing in the International Journal of Nanoparticles, Rani Pattabi and colleagues at Mangalore University, explain how blasting silver nitrate solution with an electron beam can generate nanoparticles that are more effective at killing all kinds of bacteria, including gram-negative species that are not harmed by conventional antibacterial agents.

25 May 2010

Rice University researcher receives 2010 Glycerine Innovation Award

Escherichia coli - E. coli for short - is often identified as a bacterium that contributes to foodborne illness. But research led by a Rice University scientist has discovered ways to use a safe, non-pathogenic E. coli to convert glycerine into high value fuels and chemicals.

21 May 2010

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

Human stem cells administered intravenously can restore alveolar epithelial tissue to a normal function in a novel ex vivo perfused human lung after E. coli endotoxin-induced acute lung injury, according to research from the University of California San Francisco.

18 May 2010

VBI researchers establish new tree of life for gamma-proteobacteria

A new "tree of life" has been constructed by researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech for the gamma-proteobacteria, a large group of medically and scientifically important bacteria that includes Escherichia coli, Salmonella typhimurium, and other disease-causing organisms.

18 May 2010

Nymox attributes increase in first-quarter net losses to higher clinical trial expenditures

Nymox Pharmaceutical Corporation announced today its financial results for the first quarter of 2010. Nymox reported a net loss of $1,269,550, or $0.04 per share for the quarter ending March 31, 2010, compared to $1,004,259, or $0.03 per share for same period in 2009. Net losses include stock compensation charges of $195,220 in 2010 and $309,650 in 2009.

14 May 2010

Microbiologists identify potential target in cattle to prevent E. coli strain

Microbiologists at UT Southwestern Medical Center, working with the Department of Agriculture, have identified a potential target in cattle that could be exploited to help prevent outbreaks of food-borne illnesses caused by a nasty strain of Escherichia coli.

13 May 2010

FDA, CDC confirm connection between romaine lettuce and E.coli 0145 foodborne illness outbreak

The Food and Drug Administration (FDA), with the Centers for Disease Control and Prevention (CDC) and its state health partners have confirmed that the strain of E. coli O145 detected by the New York State Public Health Laboratory, Wadsworth Center, in Albany, in an unopened bag of shredded romaine lettuce distributed by Freshway Foods, matches the outbreak strain of E. coli O145.

11 May 2010

Newly updated informational website on E. coli

An outbreak of E. coli O145 in three states has hospitalized 12, three of whom have developed hemolytic Uremic syndrome, a severe complication of E. coli infection. Victims in Michigan, Ohio, and New York are ill with E. coli O145, which has been linked to a recall of tainted lettuce by Freshway Foods.

7 May 2010

Manual provides laboratory methods, information and resources on new collection of model species

Mice, frogs, and E. coli are standard organisms in biology laboratories. But in the last few years, due in part to technical advances, the reduced costs of genome sequencing, and increased interest in evolution and development, the range of organisms used for research has greatly expanded. Scientists now have more flexibility in choosing a model system that might better address their specific research question.

7 May 2010

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

GlycoVaxyn AG, a leader in the development of innovative bioconjugate vaccines, and Professor Jean Lee, principal investigator at the Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, announced today that they have received a USD 3.4 million NIH grant to finance preclinical development of a novel Staphylococcus aureus vaccine. S. aureus is a major cause of hospital-based infections.

4 May 2010

Implementation of quality improvement intervention reduces medication use in premature babies: Study

A new study by Pediatrix Medical Group researchers has found that the implementation of a quality improvement intervention significantly reduces the use of a large number of medications in premature babies across a broad neonatal intensive care network.

3 May 2010

E. coli News and Research

Further Reading

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

Purdue University researchers develop potential new tool for medical diagnostics, testing food

BGS develops new bio filters for testing E. coli, salmonella, listeria and pseudomonas in food samples

Discovery may pave way to help reduce health hazards

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

HZI researchers develop new method to produce insulin for treatment of diabetes

Family of EPA-registered disinfecting products to be launched

Natural anti-inflammatory protein effective against meningitis-causing bacteria

Silver nanoparticles effective at killing all kinds of bacteria

Rice University researcher receives 2010 Glycerine Innovation Award

Human stem cells restore alveolar epithelial tissue after E. coli endotoxin-induced ALI: Researchers

VBI researchers establish new tree of life for gamma-proteobacteria

Nymox attributes increase in first-quarter net losses to higher clinical trial expenditures

Microbiologists identify potential target in cattle to prevent E. coli strain

FDA, CDC confirm connection between romaine lettuce and E.coli 0145 foodborne illness outbreak

Newly updated informational website on E. coli

Manual provides laboratory methods, information and resources on new collection of model species

NIH awards $3.4M grant for preclinical development of novel Staphylococcus aureus vaccine

Implementation of quality improvement intervention reduces medication use in premature babies: Study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News